跳转至内容
Merck
CN

857120P

Avanti

14:0 Lyso PA

Avanti Research - A Croda Brand

别名:

1-十四烷酰基-sn-甘油-3-磷酸(钠盐);PA(14:0/0:0);14:0 LPA;110677

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C17H34O7PNa
化学文摘社编号:
分子量:
404.41
UNSPSC Code:
51191904
NACRES:
NA.25
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

14:0 Lyso PA, 1-myristoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt), powder

InChI

1S/C17H35O7P.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-17(19)23-14-16(18)15-24-25(20,21)22;/h16,18H,2-15H2,1H3,(H2,20,21,22);/q;+1/p-1/t16-;/m1./s1

InChI key

HGENTPHNTSLRPB-PKLMIRHRSA-M

SMILES string

O[C@](COP([O-])(O)=O)([H])COC(CCCCCCCCCCCCC)=O.[Na+]

assay

>99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)

form

powder

packaging

pkg of 1 × 25 mg (857120P-25mg)
pkg of 1 × 500 mg (857120P-500mg)

manufacturer/tradename

Avanti Research - A Croda Brand 857120P

lipid type

phospholipids
cardiolipins

shipped in

dry ice

storage temp.

−20°C

Application

14:0 Lyso PA适合用作内标物以加标血清样品以提取血清脂质。它也适用于在多反应监测(MRM)分析中用作脂质提取和质量控制的标准脂质。

Biochem/physiol Actions

溶血磷脂酸(LPA)参与多种生物学功能。它是检测卵巢癌的潜在生物标志物。LPA可刺激血小板聚集、平滑肌收缩、趋化、细胞骨架重排、Ca2+动员、神经递质释放和细胞增殖。

General description

溶血磷脂酸(LPA)属于磷脂类,其甘油主链由磷酸基、脂肪链和羟基连接而成。它的磷酸基连接到sn-3位,脂肪链连接到sn-1或sn-2位,羟基连接到其余sn-1或sn-2位。

Packaging

20 mL透明玻璃螺旋盖小瓶(857120P-500mg)
5 mL棕色玻璃螺旋盖小瓶(857120P-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

存储类别

11 - Combustible Solids


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Determination of lysophosphatidic acids by capillary electrophoresis with indirect ultraviolet detection
Chen YL and Xu Y
Journal of Chromatography. B, Biomedical Sciences and Applications, 753(2), 355-363 (2001)
Ultra-high-performance liquid chromatography electrospray ionization tandem mass spectrometry for accurate analysis of glycerophospholipids and sphingolipids in drug resistance tumor cells
Li L, et al.
Journal of Chromatography A, 1381(2), 140-148 (2015)
Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column
Shan L, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 864(1-2), 22-28 (2008)
Olaposi I Omotuyi et al.
Scientific reports, 5, 13343-13343 (2015-08-14)
Lysophosphatidic acid (LPA) receptor 1 (LPA1) is a member of the G protein-coupled receptors mediating the biological response to LPA species. Lack of detailed mechanism underlying LPA/LPA1 interaction has hampered the development of specific antagonists. Here, novel N-terminal Lys39 has
Jesica R Williams et al.
The Journal of biological chemistry, 284(25), 17304-17319 (2009-04-16)
Lysophosphatidic acid (LPA) is a ligand for LPA(1-3) of the endothelial differentiation gene family G-protein-coupled receptors, and LPA(4-8) is related to the purinergic family G-protein-coupled receptor. Because the structure-activity relationship (SAR) of GPR92/LPA(5) is limited and whether LPA is its

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持